104 related articles for article (PubMed ID: 19236764)
1. [Detection and analysis of CD271, CD133 and CD34 expressions in bone marrow cells by flow cytometry with three color fluorescence labelling].
Zhou J; Zhu B; DU HY; Sun TS; Zhang CH; Yang LG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):133-6. PubMed ID: 19236764
[TBL] [Abstract][Full Text] [Related]
2. Distinct mobilization of circulating CD271+ mesenchymal progenitors from hematopoietic progenitors during aging and after myocardial infarction.
Iso Y; Yamaya S; Sato T; Poole CN; Isoyama K; Mimura M; Koba S; Kobayashi Y; Takeyama Y; Spees JL; Suzuki H
Stem Cells Transl Med; 2012 Jun; 1(6):462-8. PubMed ID: 23197850
[TBL] [Abstract][Full Text] [Related]
3. [Comparison between CD271 and CD133 used for immunomagnetic positive sorting enriching in mesenchymal stem cells from bone marrow].
Lin W; Tang XM; Kong Y; Wang H; Liu KY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):333-8. PubMed ID: 18426660
[TBL] [Abstract][Full Text] [Related]
4. [CD271 enrichment does not help isolating mesenchymal stromal cells from].
Ahrari I; Attar A; Zarandi NM; Zakerinia M; Maharlooei MK; Monabati A
Mol Biol (Mosk); 2013; 47(5):787-95. PubMed ID: 25509351
[TBL] [Abstract][Full Text] [Related]
5. CD271+, CXCR7+, CXCR4+, and CD133+ Stem/Progenitor Cells and Clinical Characteristics of Acute Ischemic Stroke Patients.
Gójska-Grymajło A; Zieliński M; Gąsecki D; Kowalczyk K; Kwarciany M; Seroczyńska B; Nyka WM
Neuromolecular Med; 2018 Sep; 20(3):301-311. PubMed ID: 29744773
[TBL] [Abstract][Full Text] [Related]
6. The CD271 expression could be alone for establisher phenotypic marker in Bone Marrow derived mesenchymal stem cells.
Flores-Torales E; Orozco-Barocio A; Gonzalez-Ramella OR; Carrasco-Yalan A; Gazarian K; Cuneo-Pareto S
Folia Histochem Cytobiol; 2010 Dec; 48(4):682-6. PubMed ID: 21478116
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction.
Turan RG; Brehm M; Koestering M; Tobias Z; Bartsch T; Steiner S; Picard F; Ebner P; Schannwell CM; Strauer BE
Eur J Clin Invest; 2007 Nov; 37(11):842-51. PubMed ID: 17973780
[TBL] [Abstract][Full Text] [Related]
8. [Are CD133 and CD271 useful in positive selection to enrich umbilical cord blood mesenchymal stem cells?].
Liu QH; Ge J; Liu KY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1286-91. PubMed ID: 21129278
[TBL] [Abstract][Full Text] [Related]
9. Role of CD271 enrichment in the isolation of mesenchymal stromal cells from umbilical cord blood.
Attar A; Ghalyanchi Langeroudi A; Vassaghi A; Ahrari I; Maharlooei MK; Monabati A
Cell Biol Int; 2013 Sep; 37(9):1010-5. PubMed ID: 23619775
[TBL] [Abstract][Full Text] [Related]
10. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.
Timmermans F; Van Hauwermeiren F; De Smedt M; Raedt R; Plasschaert F; De Buyzere ML; Gillebert TC; Plum J; Vandekerckhove B
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1572-9. PubMed ID: 17495235
[TBL] [Abstract][Full Text] [Related]
11. [Expression of CD133 in the bone marrow of patients with myelodysplastic syndrome and its clinical significance].
Zhong LY; DU X; Geng SX; Weng JY; Zheng HT; Wu SJ; Li YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):854-5. PubMed ID: 21602141
[TBL] [Abstract][Full Text] [Related]
12. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.
Wuchter C; Ratei R; Spahn G; Schoch C; Harbott J; Schnittger S; Haferlach T; Creutzig U; Sperling C; Karawajew L; Ludwig WD
Haematologica; 2001 Feb; 86(2):154-61. PubMed ID: 11224484
[TBL] [Abstract][Full Text] [Related]
13. [Expression of CD133 in bone marrow cells of patients with leukemia and myelodysplastic syndrome].
Wang W; Wang HY; Zhao HX; Cui ZG; Li GL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):470-3. PubMed ID: 17605847
[TBL] [Abstract][Full Text] [Related]
14. Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease.
Turan RG; Bozdag-Turan I; Ortak J; Akin I; Kische S; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Adolph E; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
Stem Cells Dev; 2011 Sep; 20(9):1491-501. PubMed ID: 21190450
[TBL] [Abstract][Full Text] [Related]
15. CD271(+) bone marrow mesenchymal stem cells may provide a niche for dormant Mycobacterium tuberculosis.
Das B; Kashino SS; Pulu I; Kalita D; Swami V; Yeger H; Felsher DW; Campos-Neto A
Sci Transl Med; 2013 Jan; 5(170):170ra13. PubMed ID: 23363977
[TBL] [Abstract][Full Text] [Related]
16. CD133 immunomagnetic separation: effectiveness of the method for CD133(+) isolation from umbilical cord blood.
Pelagiadis I; Relakis K; Kalmanti L; Dimitriou H
Cytotherapy; 2012 Jul; 14(6):701-6. PubMed ID: 22413760
[TBL] [Abstract][Full Text] [Related]
17. Intracoronary infusion of CD133+ and CD133-CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution.
Goussetis E; Manginas A; Koutelou M; Peristeri I; Theodosaki M; Kollaros N; Leontiadis E; Theodorakos A; Paterakis G; Karatasakis G; Cokkinos DV; Graphakos S
Stem Cells; 2006 Oct; 24(10):2279-83. PubMed ID: 16794269
[TBL] [Abstract][Full Text] [Related]
18. [Multiparametric flow cytometry analyzes the expressions of immunophenotype CD133, CD34, CD44 in lung cancer naive cells].
Liu D; Li WM; Mo XM; Liu LX; Wang Y; Che GW; Wu Z; Gou JL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):827-31. PubMed ID: 19024325
[TBL] [Abstract][Full Text] [Related]
19. Prospectively Isolated Human Bone Marrow Cell-Derived MSCs Support Primitive Human CD34-Negative Hematopoietic Stem Cells.
Matsuoka Y; Nakatsuka R; Sumide K; Kawamura H; Takahashi M; Fujioka T; Uemura Y; Asano H; Sasaki Y; Inoue M; Ogawa H; Takahashi T; Hino M; Sonoda Y
Stem Cells; 2015 May; 33(5):1554-65. PubMed ID: 25537923
[TBL] [Abstract][Full Text] [Related]
20. Migration towards SDF-1 selects angiogenin-expressing bone marrow monocytes endowed with cardiac reparative activity in patients with previous myocardial infarction.
Ascione R; Rowlinson J; Avolio E; Katare R; Meloni M; Spencer HL; Mangialardi G; Norris C; Kränkel N; Spinetti G; Emanueli C; Madeddu P
Stem Cell Res Ther; 2015 Apr; 6(1):53. PubMed ID: 25889213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
